$100m payout as talcum powder linked to ovarian cancer
THE family of a US woman whose death from ovarian cancer was linked to talcum powder has been awarded $US72 million ($A100 million).
The woman claimed she used two of Johnson & Johnson's talc-based products - Baby Powder and Shower to Shower - as feminine hygeine products for more than 35 years before being diagnosed with the disease three years ago.
She died in October last year aged 62.
Jurors in the three-week trial found the pharmaceutical company failed to warn users of the potential dangers despite concerns raised by the American Cancer